Skip to main content
Top
Published in: Supportive Care in Cancer 11/2014

01-11-2014 | Original Article

Health behaviors and needs of melanoma survivors

Authors: Oxana Palesh, Arianna Aldridge-Gerry, Kelly Bugos, David Pickham, Jie Jane Chen, Ralph Greco, Susan M. Swetter

Published in: Supportive Care in Cancer | Issue 11/2014

Login to get access

Abstract

Purpose

Little is known about melanoma survivors’ long-term symptoms, sun protection practices, and support needs from health providers.

Methods

Melanoma survivors treated at Stanford Cancer Center from 1995 through 2011 were invited to complete a heath needs survey. We compared responses of survivors by sex, education, time since diagnosis (long-term vs. short-term survivors), and extent of treatment received (wide local excision (WLE) alone versus WLE plus additional surgical or medical treatment (WLE+)).

Results

One hundred sixty melanoma survivors (51 % male; 61 % long-term; 73 % WLE+) provided evaluable data. On average, patients were 62 years of age (SD = 14), highly educated (75 % college degree), and Caucasian (94 %). Overall, participants rated anxiety as the most prevalent symptom (34 %). Seventy percent reported that their health provider did not address their symptoms, and 53 % requested education about melanoma-specific issues. Following treatment, women spent significantly less time seeking a tan compared with men (p = 0.01), had more extremity swelling (p = 0.014), and expressed higher need for additional services (p = 0.03). Long-term survivors decreased their use of tanning beds (p = 0.03) and time spent seeking a tan (p = 0.002) and were less likely to receive skin screening every 3–6 months (p < 0.001) compared with short-term survivors. WLE+ survivors reported greater physical long-term effects than WLE survivors (p ≤ 0.001) following treatment.

Conclusions

Melanoma survivors experience continuing symptoms long after treatment, namely anxiety, and they express a need for information about long-term melanoma effects, psychosocial support, and prevention of further skin cancer.
Literature
1.
go back to reference CDC (2013) Skin cancer rates by race and ethnicity 2013. Centers for Disease Control and Prevention, Atlanta, GA CDC (2013) Skin cancer rates by race and ethnicity 2013. Centers for Disease Control and Prevention, Atlanta, GA
2.
3.
go back to reference SEER (2013) SEER statistics cancer factsheets: Melanoma of the skin. National Cancer Institute, Bethesda, MD SEER (2013) SEER statistics cancer factsheets: Melanoma of the skin. National Cancer Institute, Bethesda, MD
4.
go back to reference Lin AY, Wang PF, Li H, Kolker JA (2012) Multicohort model for prevalence estimation of advanced malignant melanoma in the USA: an increasing public health concern. Melanoma Res 22(6):454–459PubMedCrossRef Lin AY, Wang PF, Li H, Kolker JA (2012) Multicohort model for prevalence estimation of advanced malignant melanoma in the USA: an increasing public health concern. Melanoma Res 22(6):454–459PubMedCrossRef
5.
go back to reference Engel J, Schlesinger-Raab A, Emeny R, Holzel D, Schubert-Fritschle G (2013) Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparison. Int J Behav Med Engel J, Schlesinger-Raab A, Emeny R, Holzel D, Schubert-Fritschle G (2013) Quality of life in women with localised breast cancer or malignant melanoma 2 years after initial treatment: a comparison. Int J Behav Med
6.
go back to reference Schlesinger-Raab A, Schubert-Fritschle G, Hein R, Stolz W, Volkenandt M, Hölzel D, Engel J (2010) Quality of life in localised malignant melanoma. Ann Oncol 21(12):2428–2435 Schlesinger-Raab A, Schubert-Fritschle G, Hein R, Stolz W, Volkenandt M, Hölzel D, Engel J (2010) Quality of life in localised malignant melanoma. Ann Oncol 21(12):2428–2435
7.
go back to reference Rychetnik L, McCaffery K, Morton R, Irwig L (2013) Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psychooncology 22(4):721–736PubMedCrossRef Rychetnik L, McCaffery K, Morton R, Irwig L (2013) Psychosocial aspects of post-treatment follow-up for stage I/II melanoma: a systematic review of the literature. Psychooncology 22(4):721–736PubMedCrossRef
8.
go back to reference Kasparian NA, McLoone JK, Butow PN (2009) Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 145(12):1415–1427PubMedCrossRef Kasparian NA, McLoone JK, Butow PN (2009) Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 145(12):1415–1427PubMedCrossRef
9.
go back to reference Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T (2001) Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 19(11):2844–2850PubMed Trask PC, Paterson AG, Hayasaka S, Dunn RL, Riba M, Johnson T (2001) Psychosocial characteristics of individuals with non-stage IV melanoma. J Clin Oncol 19(11):2844–2850PubMed
10.
go back to reference Brandberg Y, Bolund C, Sigurdardottir V, Sjoden P-O, Sullivan M (1992) Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology 1(2):71–78CrossRef Brandberg Y, Bolund C, Sigurdardottir V, Sjoden P-O, Sullivan M (1992) Anxiety and depressive symptoms at different stages of malignant melanoma. Psychooncology 1(2):71–78CrossRef
11.
go back to reference Bergenmar M, Nilsson B, Hansson J, Brandberg Y (2004) Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol 43(2):161–168PubMedCrossRef Bergenmar M, Nilsson B, Hansson J, Brandberg Y (2004) Anxiety and depressive symptoms measured by the Hospital Anxiety and Depression Scale as predictors of time to recurrence in localized cutaneous melanoma. Acta Oncol 43(2):161–168PubMedCrossRef
12.
go back to reference Kelly B, Raphael B, Smithers M, Swanson C, Reid C, McLeod R, Thomson D, Walpole E (1995) Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry 17(2):126–134 Kelly B, Raphael B, Smithers M, Swanson C, Reid C, McLeod R, Thomson D, Walpole E (1995) Psychological responses to malignant melanoma. An investigation of traumatic stress reactions to life-threatening illness. Gen Hosp Psychiatry 17(2):126–134
13.
go back to reference Boyle DA (2003) Psychological adjustment to the melanoma experience. Semin Oncol Nurs 19(1):70–77PubMedCrossRef Boyle DA (2003) Psychological adjustment to the melanoma experience. Semin Oncol Nurs 19(1):70–77PubMedCrossRef
14.
go back to reference Lehto US, Ojanen M, Kellokumpu-Lehtinen P (2005) Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Ann Oncol 16(5):805–816PubMedCrossRef Lehto US, Ojanen M, Kellokumpu-Lehtinen P (2005) Predictors of quality of life in newly diagnosed melanoma and breast cancer patients. Ann Oncol 16(5):805–816PubMedCrossRef
15.
go back to reference Atkinson TM, Noce NS, Hay J, Rafferty BT, Brady MS (2013) Illness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol 20(2):675–679PubMedCrossRefPubMedCentral Atkinson TM, Noce NS, Hay J, Rafferty BT, Brady MS (2013) Illness-related distress in women with clinically localized cutaneous melanoma. Ann Surg Oncol 20(2):675–679PubMedCrossRefPubMedCentral
16.
go back to reference Holterhues C, Cornish D, van de Poll-Franse LV, Krekels G, Koedijk F, Kuijpers D, Coebergh JW, Nijsten T (2011) Impact of melanoma on patients’ lives among 562 survivors: a Dutch population-based study. Arch Dermatol 147(2):177–185 Holterhues C, Cornish D, van de Poll-Franse LV, Krekels G, Koedijk F, Kuijpers D, Coebergh JW, Nijsten T (2011) Impact of melanoma on patients’ lives among 562 survivors: a Dutch population-based study. Arch Dermatol 147(2):177–185
17.
go back to reference Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC (2013) Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psychooncology 22(1):106–116 Oliveria SA, Shuk E, Hay JL, Heneghan M, Goulart JM, Panageas K, Geller AC, Halpern AC (2013) Melanoma survivors: health behaviors, surveillance, psychosocial factors, and family concerns. Psychooncology 22(1):106–116
18.
go back to reference Guimond S, Chatard A, Martinot D, Crisp RJ, Redersdorff S (2006) Social comparison, self-stereotyping, and gender differences in self-construals. J Pers Soc Psychol 90(2):221–242PubMedCrossRef Guimond S, Chatard A, Martinot D, Crisp RJ, Redersdorff S (2006) Social comparison, self-stereotyping, and gender differences in self-construals. J Pers Soc Psychol 90(2):221–242PubMedCrossRef
19.
go back to reference de Nooijer J, Lechner L, de Vries H (2003) Social psychological correlates of paying attention to cancer symptoms and seeking medical help. Soc Sci Med 56(5):915–920PubMedCrossRef de Nooijer J, Lechner L, de Vries H (2003) Social psychological correlates of paying attention to cancer symptoms and seeking medical help. Soc Sci Med 56(5):915–920PubMedCrossRef
20.
go back to reference Clarke SA, Booth L, Velikova G, Hewison J (2006) Social support: gender differences in cancer patients in the United Kingdom. Cancer Nurs 29(1):66–72PubMedCrossRef Clarke SA, Booth L, Velikova G, Hewison J (2006) Social support: gender differences in cancer patients in the United Kingdom. Cancer Nurs 29(1):66–72PubMedCrossRef
22.
go back to reference Nolen-Hoeksema S (2001) Gender differences in depression. Curr Dir Psychol Sci 10:173–176CrossRef Nolen-Hoeksema S (2001) Gender differences in depression. Curr Dir Psychol Sci 10:173–176CrossRef
23.
go back to reference Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV (2010) Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol 163(4):879–881PubMedCrossRef Husson O, Holterhues C, Mols F, Nijsten T, van de Poll-Franse LV (2010) Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol 163(4):879–881PubMedCrossRef
24.
go back to reference Veloso AG, Sperling C, Holm LV, Nicolaisen A, Rottmann N, Thayssen S, Christensen RD, Lehmann Knudsen J, Hansen DG. (2013) Unmet needs in cancer rehabilitation during the early cancer trajectory–a nationwide patient survey. Acta Oncol 52(2):372–381 Veloso AG, Sperling C, Holm LV, Nicolaisen A, Rottmann N, Thayssen S, Christensen RD, Lehmann Knudsen J, Hansen DG. (2013) Unmet needs in cancer rehabilitation during the early cancer trajectory–a nationwide patient survey. Acta Oncol 52(2):372–381
25.
go back to reference Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A, Mattioli V, Fosså SD (2013) Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer 119(Suppl 11):2094–2108 Rowland JH, Kent EE, Forsythe LP, Loge JH, Hjorth L, Glaser A, Mattioli V, Fosså SD (2013) Cancer survivorship research in Europe and the United States: where have we been, where are we going, and what can we learn from each other? Cancer 119(Suppl 11):2094–2108
26.
go back to reference Knobf MT, Ferrucci LM, Cartmel B, Jones BA, Stevens D, Smith M, Salner A, Mowad L (2012) Needs assessment of cancer survivors in Connecticut. J Cancer Surviv 6(1):1–10 Knobf MT, Ferrucci LM, Cartmel B, Jones BA, Stevens D, Smith M, Salner A, Mowad L (2012) Needs assessment of cancer survivors in Connecticut. J Cancer Surviv 6(1):1–10
27.
go back to reference Tambuyzer E, Van Audenhove C (2013) Is perceived patient involvement in mental health care associated with satisfaction and empowerment? Health Expect. doi:10.1111/hex.12052 Tambuyzer E, Van Audenhove C (2013) Is perceived patient involvement in mental health care associated with satisfaction and empowerment? Health Expect. doi:10.​1111/​hex.​12052
28.
go back to reference McLoone J, Menzies S, Meiser B, Mann GJ, Kasparian NA (2013) Psycho-educational interventions for melanoma survivors: a systematic review. Psychooncology 22(7):1444–1456PubMedCrossRef McLoone J, Menzies S, Meiser B, Mann GJ, Kasparian NA (2013) Psycho-educational interventions for melanoma survivors: a systematic review. Psychooncology 22(7):1444–1456PubMedCrossRef
29.
go back to reference McLoone JK, Watts KJ, Menzies SW, Barlow-Stewart K, Mann GJ, Kasparian NA (2013) Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psychooncology 22(9):1994–2000 McLoone JK, Watts KJ, Menzies SW, Barlow-Stewart K, Mann GJ, Kasparian NA (2013) Melanoma survivors at high risk of developing new primary disease: a qualitative examination of the factors that contribute to patient satisfaction with clinical care. Psychooncology 22(9):1994–2000
30.
go back to reference McLoone J, Watts KJ, Menzies S, Meiser B, Butow PN, Kasparian NA (2012) When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res 22(8):1102–1113PubMedCrossRef McLoone J, Watts KJ, Menzies S, Meiser B, Butow PN, Kasparian NA (2012) When the risks are high: psychological adjustment among melanoma survivors at high risk of developing new primary disease. Qual Health Res 22(8):1102–1113PubMedCrossRef
31.
go back to reference Murdock A, Griffin B (2013) How is patient education linked to patient satisfaction? Nursing 43(6):43–45PubMedCrossRef Murdock A, Griffin B (2013) How is patient education linked to patient satisfaction? Nursing 43(6):43–45PubMedCrossRef
32.
go back to reference Boyes AW, Girgis A, D’Este C, Zucca AC (2012) Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study. BMC Cancer 12:150PubMedCrossRefPubMedCentral Boyes AW, Girgis A, D’Este C, Zucca AC (2012) Prevalence and correlates of cancer survivors’ supportive care needs 6 months after diagnosis: a population-based cross-sectional study. BMC Cancer 12:150PubMedCrossRefPubMedCentral
33.
go back to reference White K, D’Abrew N, Katris P, O’Connor M, Emery L (2012) Mapping the psychosocial and practical support needs of cancer patients in Western Australia. Eur J Cancer Care (Engl) 21(1):107–116CrossRef White K, D’Abrew N, Katris P, O’Connor M, Emery L (2012) Mapping the psychosocial and practical support needs of cancer patients in Western Australia. Eur J Cancer Care (Engl) 21(1):107–116CrossRef
34.
go back to reference Korner A, Coroiu A, Martins C, Wang B (2013) Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient’s level of education. Int Arch Med 6(1):8PubMedCrossRefPubMedCentral Korner A, Coroiu A, Martins C, Wang B (2013) Predictors of skin self-examination before and after a melanoma diagnosis: the role of medical advice and patient’s level of education. Int Arch Med 6(1):8PubMedCrossRefPubMedCentral
Metadata
Title
Health behaviors and needs of melanoma survivors
Authors
Oxana Palesh
Arianna Aldridge-Gerry
Kelly Bugos
David Pickham
Jie Jane Chen
Ralph Greco
Susan M. Swetter
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2014
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2286-0

Other articles of this Issue 11/2014

Supportive Care in Cancer 11/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine